Transparency Market Research

D-Dimer Testing Market to Reach US $1.9 Bn by 2022

Albany, NY -- (SBWIRE) -- 09/06/2017 -- According to the research report, the global market for D-dimer testing stood at US$1.5 bn in 2013. Analysts project this market to rise at a CAGR of 2.60% between 2014 and 2022 and increase to US$1.9 bn by the end of the forecast period. D-dimer testing is majorly applied in deep vein thrombosis, disseminated intravascular coagulation, and pulmonary embolism. Among testing methods, the demand for laboratory D-dimer tests is greater than other types of D-dimer tests. The trend is anticipated to remain so over the period of the forecast. Geographically, North America, closely followed by Europe, leads the global market for D-dimer testing, thanks to the rising research activities to enhance specificities of D-dimer tests in an effort to detect any coagulation disease in the patient. Researchers anticipate this regional market to continue on the top over the forthcoming years, reports the research study.

"The increasing number of patients asking for coagulation testing is boosting the global D-dimer testing market substantially," states a TMR analyst. A number of technological advancements, such as the incorporation of highly sensitive and specified hemostasis markers for various automated instruments, and the continual observation of patients on anti-coagulation therapy are also propelling this market substantially.

Over the coming years, the support from various government across the world, in terms of funds for research and development and awareness programs intended to encourage early diagnosis of coagulation diseases, is likely to drive the growth of this market substantially in the near future, states the research report.

Fluctuation of Levels of Thrombosis in Geriatric Population to Hinder Growth

On the other hand, the difficulties faced during the interpretation of D-dimer levels in the geriatrics population pose a serious challenge for the growth of this market. The regular fluctuation in the level of thrombosis in elderly people, proving D-dimer test less useful in excluding pulmonary embolism or deep vein thrombosis, is one of the main factor behind this. The clinical adoption of point-of-care D-dimer tests in hospitals and physicians' clinics is also expected to slow down the market's growth in the years to come, reports the research study.

The global D-dimer testing market looks highly fragmented due to the presence of a large number of vendors providing kits, instruments, and regents, states a new research report by Transparency Market Research (TMR). Hitherto, the players operating in this market have been relying heavily on innovation and technological advancements for the growth of their businesses. However, they are likely to turn to mergers and acquisitions in the near future for further expansion, notes the research study. Some of the key players mentioned in this report are Abbott Laboratories, Becton, Dickinson and Co., F. Hoffman-La Roche Ltd., and Thermo Fisher Scientific.

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.